Paper37501758
VEXAS Syndrome-Review.
Zhang Y and 2 others. Glob Med Genet, 2023. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. VEXAS Syndrome-Review. Papers, record 37501758. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37501758
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33779074 | Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS. | Arthritis Rheumatol | 2021 | https://conductscience.org/library/papers/33779074 | PubMed |
| 2 | 34427584 | Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. | Blood Adv | 2021 | https://conductscience.org/library/papers/34427584 | PubMed |
| 3 | 35986821 | Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review. | Clin Rheumatol | 2022 | https://conductscience.org/library/papers/35986821 | PubMed |
| 4 | 35868738 | Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients. | RMD Open | 2022 | https://conductscience.org/library/papers/35868738 | PubMed |
| 5 | 34802546 | Toward a pathophysiology inspired treatment of VEXAS syndrome. | Semin Hematol | 2021 | https://conductscience.org/library/papers/34802546 | PubMed |
| 6 | 29104284 | JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. | Nat Rev Drug Discov | 2017 | https://conductscience.org/library/papers/29104284 | PubMed |
| 7 | 34489099 | Clinical Heterogeneity of the VEXAS Syndrome: A Case Series. | Mayo Clin Proc | 2021 | https://conductscience.org/library/papers/34489099 | PubMed |
| 8 | 35885496 | VEXAS Syndrome: A Novelty in MDS Landscape. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35885496 | PubMed |
| 9 | 23242597 | The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome. | Haematologica | 2013 | https://conductscience.org/library/papers/23242597 | PubMed |
| 10 | 36045928 | Vasculitis associated with VEXAS syndrome: A literature review. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36045928 | PubMed |
| 11 | 33971000 | VEXAS syndrome. | Blood | 2021 | https://conductscience.org/library/papers/33971000 | PubMed |
| 12 | 35419965 | VEXAS syndrome: lessons learnt from an early Australian case series. | Intern Med J | 2022 | https://conductscience.org/library/papers/35419965 | PubMed |
| 13 | 35391910 | Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome. | JAAD Case Rep | 2022 | https://conductscience.org/library/papers/35391910 | PubMed |
| 14 | 35212178 | Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series. | Arthritis Rheumatol | 2022 | https://conductscience.org/library/papers/35212178 | PubMed |
| 15 | 35793467 | Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. | Blood | 2022 | https://conductscience.org/library/papers/35793467 | PubMed |
| 16 | 34048852 | Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS. | J Allergy Clin Immunol | 2022 | https://conductscience.org/library/papers/34048852 | PubMed |
| 17 | 36104395 | A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML. | Leukemia | 2022 | https://conductscience.org/library/papers/36104395 | PubMed |
| 18 | 33619558 | Therapeutic options in VEXAS syndrome: insights from a retrospective series. | Blood | 2021 | https://conductscience.org/library/papers/33619558 | PubMed |
| 19 | 34649277 | A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm. | Blood Adv | 2022 | https://conductscience.org/library/papers/34649277 | PubMed |
| 20 | 34999727 | Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report. | Bone Marrow Transplant | 2022 | https://conductscience.org/library/papers/34999727 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353870 | VEXAS Syndrome Beyond UBA1: Genetic Architecture and the Role of Co-Occurring Somatic Mutations-A Focused Review. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42353870 | PubMed |
| 42316235 | Clinical characteristics and a screening tool for VEXAS syndrome: a case-control study from China. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42316235 | PubMed |
| 41704985 | Expanding the Clinical Spectrum of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome: The First Report of Histologically Confirmed Neutrophilic Colitis With Rare Muscular and Pancreatic Involvement. | Cureus | 2026 | https://conductscience.org/library/papers/41704985 | PubMed |
| 41630701 | A fatal case of VEXAS syndrome with a brief review. | J Vasc Surg Cases Innov Tech | 2026 | https://conductscience.org/library/papers/41630701 | PubMed |
| 41450412 | A Vexing Diagnosis: ENT Presentation of Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome. | Cureus | 2025 | https://conductscience.org/library/papers/41450412 | PubMed |
| 41246582 | Unravelling the Puzzle: Highlighting a Case of VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Mimicker Presented With Inflammatory Symptoms and Pancytopenia. | Cureus | 2025 | https://conductscience.org/library/papers/41246582 | PubMed |
| 40928138 | VEXAS Syndrome and Substance Use Disorders: A Large-Scale, Propensity-Matched, Case-Control Analysis Revealing Immune-Mediated Comorbidities. | Int J Dermatol | 2026 | https://conductscience.org/library/papers/40928138 | PubMed |
| 40718755 | Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature. | Open Access Rheumatol | 2025 | https://conductscience.org/library/papers/40718755 | PubMed |
| 40650768 | VEXAS syndrome-associated tumefactive demyelination. | J Neurol | 2025 | https://conductscience.org/library/papers/40650768 | PubMed |
| 40637274 | Multiple Erythematous Oedematous Plaques on the Neck of a 68-year-old Man: A Quiz. | Acta Derm Venereol | 2025 | https://conductscience.org/library/papers/40637274 | PubMed |
| 40326802 | VEXAS Syndrome: An Overlooked Threat. | Balkan Med J | 2025 | https://conductscience.org/library/papers/40326802 | PubMed |
| 40104273 | VEXAS syndrome with p.Met41Leu UBA1 gene mutation misdiagnosed as tumid lupus: A series of 3 cases. | JAAD Case Rep | 2025 | https://conductscience.org/library/papers/40104273 | PubMed |
| 39982357 | Utilizing C. elegans Spermatogenesis and Fertilization Mutants as a Model for Human Disease. | J Dev Biol | 2025 | https://conductscience.org/library/papers/39982357 | PubMed |
| 39865233 | VEXAS, Chediak-Higashi syndrome and Danon disease: myeloid cell endo-lysosomal pathway dysfunction as a common denominator? | Cell Mol Biol Lett | 2025 | https://conductscience.org/library/papers/39865233 | PubMed |
| 39598114 | VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments. | J Clin Med | 2024 | https://conductscience.org/library/papers/39598114 | PubMed |
| 39385260 | Rare primary vasculitis: update on multiple complex diseases and the new kids on the block. | Adv Rheumatol | 2024 | https://conductscience.org/library/papers/39385260 | PubMed |
| 39175060 | Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approaches. | Adv Rheumatol | 2024 | https://conductscience.org/library/papers/39175060 | PubMed |
| 37961826 | The Emerging Spectrum of Somatic Mutation in Rheumatic Disease: Clonal Hematopoiesis Connects Aging With Giant Cell Arteritis. | Arthritis Rheumatol | 2024 | https://conductscience.org/library/papers/37961826 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37501758
GET https://conductscience.org/api/papers/v1/37501758/references?page=2